tirzepatide retatrutide vs. Tirzepatide: The Next-Gen GLP-1 Showdown Retatrutide vs Tirzepatide: Triple vs

Both are once-weekly subcutaneous injections titrated upward over weeks to a maintenance dose, a schedule designed to blunt gastrointestinal side effects

Despite its unlicensed status, retatrutide has begun appearing on the grey market, often sold as a 'research peptide' or 'research chemical'

Not only are there currently millions of people on these compounded drugs, all of whom would have to get new prescriptions to switch over to brand-name ones, but the market is ever-growing as these drugs gain new approved uses, like sleep apnea

However, some studies have reported that rosiglitazone and pioglitazone, both TZD drugs, could be associated with an increased risk of prostate and pancreatic cancer [107]

Can I drink alcohol while on GLP-1